Sealantis

Alga-mimetic Tissue Adhesives

Health Tech & Life Sciences
Acquired (Inactive) by Advanced Medical Solutions Group on Jan 2019 - closed due to acquisition
Follow

Company Overview

Snapshot

Founded in January 2007 by Prof. Havazelet Bianco-Peled, Sealantis operates with 11–50 employees. The company was acquired by Advanced Medical Solutions Group in January 2019.

Business overview

Sealantis, now AMS Israel, develops protein-free tissue adhesives utilizing proprietary alga-mimetic formulations for diverse surgical applications. Its core technology mimics the underwater adherence mechanism of algae. The company's product portfolio includes Seal-V, a surgical sealant for vascular procedures, Seal-G, a bioresorbable sealant for gastrointestinal anastomoses, and the Orthopedic Adhesion Barrier, a bioresorbable gel to prevent tissue adhesions in injured joints. Sealantis operates within the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology, Drug Delivery, and Biomaterials & Tissue Engineering, serving the healthcare provider market.

Strategic signal

In January 2018, Sealantis received CE marking for its Seal-G surgical sealant for gastrointestinal procedures. This regulatory approval was a significant validation of the product's safety and efficacy, indicating market readiness and potential for commercial expansion in Europe, thereby signaling a key milestone for investors in the medical device and biomaterials space.

Log in to access full profile

Company Intelligence Q&A

When was Sealantis acquired?
Sealantis was acquired by Advanced Medical Solutions Group in January 2019.
What is Seal-G?
Seal-G is a gastrointestinal bioresorbable sealant developed by Sealantis, designed to secure gastrointestinal anastomoses and reduce complications from postsurgical leaks.
What is Seal-V?
Seal-V is a surgical sealant developed by Sealantis, designed for use in various vascular procedures to control bleeding.
What is the core technology behind Sealantis' products?
Sealantis develops protein-free tissue adhesives based on proprietary alga-mimetic formulations, mimicking the underwater adherence mechanism of algae.
Did Sealantis receive any regulatory approvals for its products?
In January 2018, Sealantis received the CE mark for its Seal-G surgical sealant for gastrointestinal procedures.
Log in to access full profile